Your browser doesn't support javascript.
Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.
Cheng, Matthew P; Cau, Alessandro; Lee, Todd C; Brodie, Daniel; Slutsky, Arthur; Marshall, John; Murthy, Srin; Lee, Terry; Singer, Joel; Demir, Koray K; Boyd, John; Ohm, Hyejee; Maslove, David; Goffi, Alberto; Bogoch, Isaac I; Sweet, David D; Walley, Keith R; Russell, James A.
  • Cheng MP; Department of Medicine, McGill University, Montreal, QC, Canada.
  • Cau A; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Lee TC; Department of Medicine, McGill University, Montreal, QC, Canada.
  • Brodie D; Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York Presbyterian Hospital, Columbia University, New York, NY.
  • Slutsky A; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Marshall J; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Murthy S; Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Lee T; Centre for Health Evaluation and Outcomes Science (CHEOS), University of British Columbia, Vancouver, BC, Canada.
  • Singer J; Centre for Health Evaluation and Outcomes Science (CHEOS), University of British Columbia, Vancouver, BC, Canada.
  • Demir KK; Department of Medicine, McGill University, Montreal, QC, Canada.
  • Boyd J; Department of Medicine, Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Ohm H; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Maslove D; Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada.
  • Goffi A; Department of Medicine and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
  • Bogoch II; Divisions of Internal Medicine and Infectious Diseases, Department of Medicine, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Sweet DD; Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Walley KR; Department of Medicine, Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Russell JA; Department of Medicine, Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Crit Care Med ; 49(9): 1558-1566, 2021 09 01.
Article in English | MEDLINE | ID: covidwho-1191495
ABSTRACT

OBJECTIVES:

Severe acute respiratory syndrome-related coronavirus-2 binds and inhibits angiotensin-converting enzyme-2. The frequency of acute cardiac injury in patients with coronavirus disease 2019 is unknown. The objective was to compare the rates of cardiac injury by angiotensin-converting enzyme-2-binding viruses from viruses that do not bind to angiotensin-converting enzyme-2. DATA SOURCES We performed a systematic review of coronavirus disease 2019 literature on PubMed and EMBASE. STUDY SELECTION We included studies with ten or more hospitalized adults with confirmed coronavirus disease 2019 or other viral pathogens that described the occurrence of acute cardiac injury. This was defined by the original publication authors or by 1) myocardial ischemia, 2) new cardiac arrhythmia on echocardiogram, or 3) new or worsening heart failure on echocardiogram. DATA EXTRACTION We compared the rates of cardiac injury among patients with respiratory infections with viruses that down-regulate angiotensin-converting enzyme-2, including H1N1, H5N1, H7N9, and severe acute respiratory syndrome-related coronavirus-1, to those with respiratory infections from other influenza viruses that do not bind angiotensin-converting enzyme-2, including Influenza H3N2 and influenza B. DATA

SYNTHESIS:

Of 57 studies including 34,072 patients, acute cardiac injury occurred in 50% (95% CI, 44-57%) of critically ill patients with coronavirus disease 2019. The overall risk of acute cardiac injury was 21% (95% CI, 18-26%) among hospitalized patients with coronavirus disease 2019. In comparison, 37% (95% CI, 26-49%) of critically ill patients with other respiratory viruses that bind angiotensin-converting enzyme-2 (p = 0.061) and 12% (95% CI, 7-22%) of critically ill patients with other respiratory viruses that do not bind angiotensin-converting enzyme-2 (p < 0.001) experienced a cardiac injury.

CONCLUSIONS:

Acute cardiac injury may be associated with whether the virus binds angiotensin-converting enzyme-2. Acute cardiac injury occurs in half of critically ill coronavirus disease 2019 patients, but only 12% of patients infected by viruses that do not bind to angiotensin-converting enzyme-2.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Myocardial Ischemia / Influenza, Human / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Heart Failure Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Crit Care Med Year: 2021 Document Type: Article Affiliation country: CCM.0000000000005026

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Myocardial Ischemia / Influenza, Human / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Heart Failure Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Crit Care Med Year: 2021 Document Type: Article Affiliation country: CCM.0000000000005026